Skip to main content
Erschienen in: European Journal of Epidemiology 3/2020

16.03.2020 | UMBRELLA REVIEW

Environmental factors, serum biomarkers and risk of atrial fibrillation: an exposure-wide umbrella review of meta-analyses

verfasst von: Lazaros Belbasis, Michail C. Mavrogiannis, Maria Emfietzoglou, Evangelos Evangelou

Erschienen in: European Journal of Epidemiology | Ausgabe 3/2020

Einloggen, um Zugang zu erhalten

Abstract

Atrial fibrillation (AF) is the most common cardiac arrhythmia. We designed an umbrella review to systematically assess the epidemiological credibility of the associations of non-genetic factors with risk of AF. We searched PubMed and EMBASE from inception to December 31, 2018 to identify systematic reviews and meta-analyses of observational studies for the association of non-genetic factors with risk of AF. For each meta-analysis, we used the random-effects model, and we estimated the 95% confidence and prediction intervals. We also assessed between-study heterogeneity, small-study effects and excess significance bias. We identified 34 eligible papers that examined 51 associations of 42 unique non-genetic factors with risk of AF. Eighteen associations remained statistically significant at P value < 1 × 10−6. Thirty-one associations presented large or very large between-study heterogeneity. Eight associations presented evidence for small-study effects and 13 associations had evidence for excess significance bias. Ten associations, i.e. corrected QT interval, alcohol consumption (highest vs. lowest category, per 1 drink/day increase), body mass index (> 30 units vs. < 30 units, per 5 units increase), waist circumference, body weight, type 2 diabetes mellitus, and smoking (ever vs. never, per 10 cigarettes/day increase) were supported by convincing or highly suggestive evidence in meta-analyses of prospective cohort studies. Type 2 diabetes mellitus, markers of adiposity, alcohol consumption, smoking, and corrected QT interval constitute credible risk factors of AF. Our proposed grading may guide the design of future studies, including Mendelian randomization studies, to assess whether these associations are causal.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Rienstra M, McManus DD, Benjamin EJ. Novel risk factors for atrial fibrillation: useful for risk prediction and clinical decision making? Circulation. 2012;125:e941–6.PubMedPubMedCentral Rienstra M, McManus DD, Benjamin EJ. Novel risk factors for atrial fibrillation: useful for risk prediction and clinical decision making? Circulation. 2012;125:e941–6.PubMedPubMedCentral
2.
Zurück zum Zitat Chugh SS, Havmoeller R, Narayanan K, Singh D, Rienstra M, Benjamin EJ, et al. Worldwide epidemiology of atrial fibrillation. Circulation. 2014;129:837–47.PubMed Chugh SS, Havmoeller R, Narayanan K, Singh D, Rienstra M, Benjamin EJ, et al. Worldwide epidemiology of atrial fibrillation. Circulation. 2014;129:837–47.PubMed
3.
Zurück zum Zitat Chugh SS, Roth GA, Gillum RF, Mensah GA. Global burden of atrial fibrillation in developed and developing nations. Glob Heart. 2014;9:113–9.PubMed Chugh SS, Roth GA, Gillum RF, Mensah GA. Global burden of atrial fibrillation in developed and developing nations. Glob Heart. 2014;9:113–9.PubMed
4.
Zurück zum Zitat Lip GY, Tse HF, Lane DA. Atrial fibrillation. Lancet. 2012;379:648–61.PubMed Lip GY, Tse HF, Lane DA. Atrial fibrillation. Lancet. 2012;379:648–61.PubMed
5.
Zurück zum Zitat Odutayo A, Wong CX, Hsiao AJ, Hopewell S, Altman DG, Emdin CA. Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis. BMJ. 2016;354:i4482.PubMed Odutayo A, Wong CX, Hsiao AJ, Hopewell S, Altman DG, Emdin CA. Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis. BMJ. 2016;354:i4482.PubMed
6.
Zurück zum Zitat Lau DH, Nattel S, Kalman JM, Sanders P. Modifiable risk factors and atrial fibrillation. Circulation. 2017;136:583–96.PubMed Lau DH, Nattel S, Kalman JM, Sanders P. Modifiable risk factors and atrial fibrillation. Circulation. 2017;136:583–96.PubMed
7.
Zurück zum Zitat Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37:2893–962.PubMed Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37:2893–962.PubMed
8.
Zurück zum Zitat Benjamin EJ, Chen P-S, Bild DE, Mascette AM, Albert CM, Alonso A, et al. Prevention of atrial fibrillation. Circulation. 2009;119:606–18.PubMedPubMedCentral Benjamin EJ, Chen P-S, Bild DE, Mascette AM, Albert CM, Alonso A, et al. Prevention of atrial fibrillation. Circulation. 2009;119:606–18.PubMedPubMedCentral
9.
Zurück zum Zitat Ioannidis JPA. Integration of evidence from multiple meta-analyses: a primer on umbrella reviews, treatment networks and multiple treatments meta-analyses. CMAJ. 2009;181:488–93.PubMedPubMedCentral Ioannidis JPA. Integration of evidence from multiple meta-analyses: a primer on umbrella reviews, treatment networks and multiple treatments meta-analyses. CMAJ. 2009;181:488–93.PubMedPubMedCentral
10.
Zurück zum Zitat Bellou V, Belbasis L, Tzoulaki I, Evangelou E, Ioannidis JPA. Environmental risk factors and Parkinson’s disease: an umbrella review of meta-analyses. Parkinsonism Relat Disord. 2016;23:1–9.PubMed Bellou V, Belbasis L, Tzoulaki I, Evangelou E, Ioannidis JPA. Environmental risk factors and Parkinson’s disease: an umbrella review of meta-analyses. Parkinsonism Relat Disord. 2016;23:1–9.PubMed
11.
Zurück zum Zitat Bellou V, Belbasis L, Tzoulaki I, Middleton LT, Ioannidis JPA, Evangelou E. Systematic evaluation of the associations between environmental risk factors and dementia: an umbrella review of systematic reviews and meta-analyses. Alzheimers Dement. 2017;13:406–18.PubMed Bellou V, Belbasis L, Tzoulaki I, Middleton LT, Ioannidis JPA, Evangelou E. Systematic evaluation of the associations between environmental risk factors and dementia: an umbrella review of systematic reviews and meta-analyses. Alzheimers Dement. 2017;13:406–18.PubMed
12.
Zurück zum Zitat Belbasis L, Stefanaki I, Stratigos AJ, Evangelou E. Non-genetic risk factors for cutaneous melanoma and keratinocyte skin cancers: an umbrella review of meta-analyses. J Dermatol Sci. 2016;84:330–9.PubMed Belbasis L, Stefanaki I, Stratigos AJ, Evangelou E. Non-genetic risk factors for cutaneous melanoma and keratinocyte skin cancers: an umbrella review of meta-analyses. J Dermatol Sci. 2016;84:330–9.PubMed
13.
Zurück zum Zitat Bellou V, Belbasis L, Tzoulaki I, Evangelou E. Risk factors for type 2 diabetes mellitus: an exposure-wide umbrella review of meta-analyses. PLoS ONE. 2018;13:e0194127.PubMedPubMedCentral Bellou V, Belbasis L, Tzoulaki I, Evangelou E. Risk factors for type 2 diabetes mellitus: an exposure-wide umbrella review of meta-analyses. PLoS ONE. 2018;13:e0194127.PubMedPubMedCentral
14.
Zurück zum Zitat Belbasis L, Dosis V, Evangelou E. Elucidating the environmental risk factors for rheumatic diseases: an umbrella review of meta-analyses. Int J Rheum Dis. 2018;21:1514–24.PubMed Belbasis L, Dosis V, Evangelou E. Elucidating the environmental risk factors for rheumatic diseases: an umbrella review of meta-analyses. Int J Rheum Dis. 2018;21:1514–24.PubMed
15.
Zurück zum Zitat Bellou V, Belbasis L, Konstantinidis AK, Evangelou E. Elucidating the risk factors for chronic obstructive pulmonary disease: an umbrella review of meta-analyses. Int J Tuberc Lung Dis. 2019;23:58–66.PubMed Bellou V, Belbasis L, Konstantinidis AK, Evangelou E. Elucidating the risk factors for chronic obstructive pulmonary disease: an umbrella review of meta-analyses. Int J Tuberc Lung Dis. 2019;23:58–66.PubMed
16.
Zurück zum Zitat Belbasis L, Savvidou MD, Kanu C, Evangelou E, Tzoulaki I. Birth weight in relation to health and disease in later life: an umbrella review of systematic reviews and meta-analyses. BMC Med. 2016;14:147.PubMedPubMedCentral Belbasis L, Savvidou MD, Kanu C, Evangelou E, Tzoulaki I. Birth weight in relation to health and disease in later life: an umbrella review of systematic reviews and meta-analyses. BMC Med. 2016;14:147.PubMedPubMedCentral
17.
Zurück zum Zitat DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.PubMed DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.PubMed
18.
Zurück zum Zitat Lau J, Ioannidis JP, Schmid CH. Quantitative synthesis in systematic reviews. Ann Intern Med. 1997;127:820–6.PubMed Lau J, Ioannidis JP, Schmid CH. Quantitative synthesis in systematic reviews. Ann Intern Med. 1997;127:820–6.PubMed
19.
Zurück zum Zitat Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–58.PubMed Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–58.PubMed
20.
21.
Zurück zum Zitat Higgins JPT, Thompson SG, Spiegelhalter DJ. A re-evaluation of random-effects meta-analysis. J R Stat Soc Ser A Stat Soc. 2009;172:137–59.PubMedPubMedCentral Higgins JPT, Thompson SG, Spiegelhalter DJ. A re-evaluation of random-effects meta-analysis. J R Stat Soc Ser A Stat Soc. 2009;172:137–59.PubMedPubMedCentral
22.
Zurück zum Zitat Higgins JPT. Commentary: heterogeneity in meta-analysis should be expected and appropriately quantified. Int J Epidemiol. 2008;37:1158–60.PubMed Higgins JPT. Commentary: heterogeneity in meta-analysis should be expected and appropriately quantified. Int J Epidemiol. 2008;37:1158–60.PubMed
23.
Zurück zum Zitat Sterne JAC, Sutton AJ, Ioannidis JPA, Terrin N, Jones DR, Lau J, et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ. 2011;343:d4002.PubMed Sterne JAC, Sutton AJ, Ioannidis JPA, Terrin N, Jones DR, Lau J, et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ. 2011;343:d4002.PubMed
24.
Zurück zum Zitat Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34.PubMedPubMedCentral Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34.PubMedPubMedCentral
25.
Zurück zum Zitat Ioannidis JPA, Trikalinos TA. An exploratory test for an excess of significant findings. Clin Trials. 2007;4:245–53.PubMed Ioannidis JPA, Trikalinos TA. An exploratory test for an excess of significant findings. Clin Trials. 2007;4:245–53.PubMed
26.
Zurück zum Zitat Ioannidis JPA. Clarifications on the application and interpretation of the test for excess significance and its extensions. J Math Psychol. 2013;57:184–7. Ioannidis JPA. Clarifications on the application and interpretation of the test for excess significance and its extensions. J Math Psychol. 2013;57:184–7.
27.
Zurück zum Zitat Lubin JH, Gail MH. On power and sample size for studying features of the relative odds of disease. Am J Epidemiol. 1990;131:552–66.PubMed Lubin JH, Gail MH. On power and sample size for studying features of the relative odds of disease. Am J Epidemiol. 1990;131:552–66.PubMed
28.
Zurück zum Zitat Baumgartner C, da Costa BR, Collet T-H, Feller M, Floriani C, Bauer DC, et al. Thyroid function within the normal range, subclinical hypothyroidism, and the risk of atrial fibrillation. Circulation. 2017;136:2100–16.PubMedPubMedCentral Baumgartner C, da Costa BR, Collet T-H, Feller M, Floriani C, Bauer DC, et al. Thyroid function within the normal range, subclinical hypothyroidism, and the risk of atrial fibrillation. Circulation. 2017;136:2100–16.PubMedPubMedCentral
29.
Zurück zum Zitat Kivimäki M, Nyberg ST, Batty GD, Kawachi I, Jokela M, Alfredsson L, et al. Long working hours as a risk factor for atrial fibrillation: a multi-cohort study. Eur Heart J. 2017;38:2621–8.PubMedPubMedCentral Kivimäki M, Nyberg ST, Batty GD, Kawachi I, Jokela M, Alfredsson L, et al. Long working hours as a risk factor for atrial fibrillation: a multi-cohort study. Eur Heart J. 2017;38:2621–8.PubMedPubMedCentral
30.
Zurück zum Zitat Larsson SC, Drca N, Wolk A. Alcohol consumption and risk of atrial fibrillation: a prospective study and dose-response meta-analysis. J Am Coll Cardiol. 2014;64:281–9.PubMed Larsson SC, Drca N, Wolk A. Alcohol consumption and risk of atrial fibrillation: a prospective study and dose-response meta-analysis. J Am Coll Cardiol. 2014;64:281–9.PubMed
31.
Zurück zum Zitat Sidhu K, Tang A. Modifiable risk factors in atrial fibrillation: the role of alcohol, obesity, and sleep apnea. Can J Cardiol. 2017;33:947–9.PubMed Sidhu K, Tang A. Modifiable risk factors in atrial fibrillation: the role of alcohol, obesity, and sleep apnea. Can J Cardiol. 2017;33:947–9.PubMed
32.
Zurück zum Zitat Voskoboinik A, Prabhu S, Ling L, Kalman JM, Kistler PM. Alcohol and atrial fibrillation. J Am Coll Cardiol. 2016;68:2567–76.PubMed Voskoboinik A, Prabhu S, Ling L, Kalman JM, Kistler PM. Alcohol and atrial fibrillation. J Am Coll Cardiol. 2016;68:2567–76.PubMed
33.
Zurück zum Zitat Fabritz L, Guasch E, Antoniades C, Bardinet I, Benninger G, Betts TR, et al. Defining the major health modifiers causing atrial fibrillation: a roadmap to underpin personalized prevention and treatment. Nat Rev Cardiol. 2016;13:230–7.PubMed Fabritz L, Guasch E, Antoniades C, Bardinet I, Benninger G, Betts TR, et al. Defining the major health modifiers causing atrial fibrillation: a roadmap to underpin personalized prevention and treatment. Nat Rev Cardiol. 2016;13:230–7.PubMed
34.
Zurück zum Zitat Chatterjee NA, Giulianini F, Geelhoed B, Lunetta KL, Misialek JR, Niemeijer MN, et al. Genetic obesity and the risk of atrial fibrillation: causal estimates from Mendelian randomization. Circulation. 2017;135:741–54.PubMed Chatterjee NA, Giulianini F, Geelhoed B, Lunetta KL, Misialek JR, Niemeijer MN, et al. Genetic obesity and the risk of atrial fibrillation: causal estimates from Mendelian randomization. Circulation. 2017;135:741–54.PubMed
35.
Zurück zum Zitat Tikkanen E, Gustafsson S, Knowles JW, Perez M, Burgess S, Ingelsson E. Body composition and atrial fibrillation: a Mendelian randomization study. Eur Heart J. 2019;40:1277–82.PubMedPubMedCentral Tikkanen E, Gustafsson S, Knowles JW, Perez M, Burgess S, Ingelsson E. Body composition and atrial fibrillation: a Mendelian randomization study. Eur Heart J. 2019;40:1277–82.PubMedPubMedCentral
36.
Zurück zum Zitat Rabkin SW. The relationship between epicardial fat and indices of obesity and the metabolic syndrome: a systematic review and meta-analysis. Metab Syndr Relat Disord. 2014;12:31–42.PubMed Rabkin SW. The relationship between epicardial fat and indices of obesity and the metabolic syndrome: a systematic review and meta-analysis. Metab Syndr Relat Disord. 2014;12:31–42.PubMed
37.
Zurück zum Zitat Wong CX, Sun MT, Odutayo A, Emdin CA, Mahajan R, Lau DH, et al. Associations of epicardial, abdominal, and overall adiposity with atrial fibrillation. Circ Arrhythm Electrophysiol. 2016;9:e004378.PubMed Wong CX, Sun MT, Odutayo A, Emdin CA, Mahajan R, Lau DH, et al. Associations of epicardial, abdominal, and overall adiposity with atrial fibrillation. Circ Arrhythm Electrophysiol. 2016;9:e004378.PubMed
38.
Zurück zum Zitat Lau DH, Schotten U, Mahajan R, Antic NA, Hatem SN, Pathak RK, et al. Novel mechanisms in the pathogenesis of atrial fibrillation: practical applications. Eur Heart J. 2016;37:1573–81.PubMed Lau DH, Schotten U, Mahajan R, Antic NA, Hatem SN, Pathak RK, et al. Novel mechanisms in the pathogenesis of atrial fibrillation: practical applications. Eur Heart J. 2016;37:1573–81.PubMed
39.
Zurück zum Zitat Aune D, Feng T, Schlesinger S, Janszky I, Norat T, Riboli E. Diabetes mellitus, blood glucose and the risk of atrial fibrillation: a systematic review and meta-analysis of cohort studies. J Diabetes Complicat. 2018;32:501–11. Aune D, Feng T, Schlesinger S, Janszky I, Norat T, Riboli E. Diabetes mellitus, blood glucose and the risk of atrial fibrillation: a systematic review and meta-analysis of cohort studies. J Diabetes Complicat. 2018;32:501–11.
40.
Zurück zum Zitat Harati H, Zanetti D, Rao A, Gustafsson S, Perez M, Ingelsson E, et al. No evidence of a causal association of type 2 diabetes and glucose metabolism with atrial fibrillation. Diabetologia. 2019;62:800–4.PubMedPubMedCentral Harati H, Zanetti D, Rao A, Gustafsson S, Perez M, Ingelsson E, et al. No evidence of a causal association of type 2 diabetes and glucose metabolism with atrial fibrillation. Diabetologia. 2019;62:800–4.PubMedPubMedCentral
41.
Zurück zum Zitat Freedman B, Camm J, Calkins H, Healey JS, Rosenqvist M, Wang J, et al. Screening for atrial fibrillation: a report of the AF-SCREEN international collaboration. Circulation. 2017;135:1851–67.PubMed Freedman B, Camm J, Calkins H, Healey JS, Rosenqvist M, Wang J, et al. Screening for atrial fibrillation: a report of the AF-SCREEN international collaboration. Circulation. 2017;135:1851–67.PubMed
42.
Zurück zum Zitat US Preventive Services Task Force, Curry SJ, Krist AH, Owens DK, Barry MJ, Caughey AB, et al. Screening for atrial fibrillation with electrocardiography: US preventive services task force recommendation statement. JAMA. 2018;320:478–84. US Preventive Services Task Force, Curry SJ, Krist AH, Owens DK, Barry MJ, Caughey AB, et al. Screening for atrial fibrillation with electrocardiography: US preventive services task force recommendation statement. JAMA. 2018;320:478–84.
43.
Zurück zum Zitat Ioannidis JPA, Boffetta P, Little J, O’Brien TR, Uitterlinden AG, Vineis P, et al. Assessment of cumulative evidence on genetic associations: interim guidelines. Int J Epidemiol. 2008;37:120–32.PubMed Ioannidis JPA, Boffetta P, Little J, O’Brien TR, Uitterlinden AG, Vineis P, et al. Assessment of cumulative evidence on genetic associations: interim guidelines. Int J Epidemiol. 2008;37:120–32.PubMed
44.
Zurück zum Zitat Benjamin DJ, Berger JO, Johannesson M, Nosek BA, Wagenmakers E-J, Berk R, et al. Redefine statistical significance. Nat Hum Behav. 2018;2:6–10.PubMed Benjamin DJ, Berger JO, Johannesson M, Nosek BA, Wagenmakers E-J, Berk R, et al. Redefine statistical significance. Nat Hum Behav. 2018;2:6–10.PubMed
45.
46.
Zurück zum Zitat Riley RD, Lambert PC, Abo-Zaid G. Meta-analysis of individual participant data: rationale, conduct, and reporting. BMJ. 2010;340:c221.PubMed Riley RD, Lambert PC, Abo-Zaid G. Meta-analysis of individual participant data: rationale, conduct, and reporting. BMJ. 2010;340:c221.PubMed
47.
Zurück zum Zitat Alonso A, Misialek JR, Michos ED, Eckfeldt J, Selvin E, Soliman EZ, et al. Serum 25-hydroxyvitamin D and the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study. Europace. 2016;18:1143–9.PubMedPubMedCentral Alonso A, Misialek JR, Michos ED, Eckfeldt J, Selvin E, Soliman EZ, et al. Serum 25-hydroxyvitamin D and the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study. Europace. 2016;18:1143–9.PubMedPubMedCentral
48.
Zurück zum Zitat Asad Z, Abbas M, Javed I, Korantzopoulos P, Stavrakis S. Obesity is associated with incident atrial fibrillation independent of gender: a meta-analysis. J Cardiovasc Electrophysiol. 2018;29:725–32.PubMed Asad Z, Abbas M, Javed I, Korantzopoulos P, Stavrakis S. Obesity is associated with incident atrial fibrillation independent of gender: a meta-analysis. J Cardiovasc Electrophysiol. 2018;29:725–32.PubMed
49.
Zurück zum Zitat Aune D, Sen A, Ó’Hartaigh B, Janszky I, Romundstad PR, Tonstad S, et al. Resting heart rate and the risk of cardiovascular disease, total cancer, and all-cause mortality—a systematic review and dose-response meta-analysis of prospective studies. Nutr Metab Cardiovasc Dis. 2017;27:504–17.PubMed Aune D, Sen A, Ó’Hartaigh B, Janszky I, Romundstad PR, Tonstad S, et al. Resting heart rate and the risk of cardiovascular disease, total cancer, and all-cause mortality—a systematic review and dose-response meta-analysis of prospective studies. Nutr Metab Cardiovasc Dis. 2017;27:504–17.PubMed
50.
Zurück zum Zitat Aune D, Sen A, Schlesinger S, Norat T, Janszky I, Romundstad P, et al. Body mass index, abdominal fatness, fat mass and the risk of atrial fibrillation: a systematic review and dose-response meta-analysis of prospective studies. Eur J Epidemiol. 2017;32:181–92.PubMedPubMedCentral Aune D, Sen A, Schlesinger S, Norat T, Janszky I, Romundstad P, et al. Body mass index, abdominal fatness, fat mass and the risk of atrial fibrillation: a systematic review and dose-response meta-analysis of prospective studies. Eur J Epidemiol. 2017;32:181–92.PubMedPubMedCentral
51.
Zurück zum Zitat Aune D, Schlesinger S, Norat T, Riboli E. Tobacco smoking and the risk of atrial fibrillation: a systematic review and meta-analysis of prospective studies. Eur J Prev Cardiol. 2018;25:1437–51.PubMed Aune D, Schlesinger S, Norat T, Riboli E. Tobacco smoking and the risk of atrial fibrillation: a systematic review and meta-analysis of prospective studies. Eur J Prev Cardiol. 2018;25:1437–51.PubMed
52.
Zurück zum Zitat Bang CN, Greve AM, Abdulla J, Køber L, Gislason GH, Wachtell K. The preventive effect of statin therapy on new-onset and recurrent atrial fibrillation in patients not undergoing invasive cardiac interventions: a systematic review and meta-analysis. Int J Cardiol. 2013;167:624–30.PubMed Bang CN, Greve AM, Abdulla J, Køber L, Gislason GH, Wachtell K. The preventive effect of statin therapy on new-onset and recurrent atrial fibrillation in patients not undergoing invasive cardiac interventions: a systematic review and meta-analysis. Int J Cardiol. 2013;167:624–30.PubMed
53.
Zurück zum Zitat Cardoso R, Garcia D, Fernandes G, He LI, Lichtenberger P, Viles-Gonzalez J, et al. The prevalence of atrial fibrillation and conduction abnormalities in Chagas’ disease: a meta-analysis. J Cardiovasc Electrophysiol. 2016;27:161–9.PubMed Cardoso R, Garcia D, Fernandes G, He LI, Lichtenberger P, Viles-Gonzalez J, et al. The prevalence of atrial fibrillation and conduction abnormalities in Chagas’ disease: a meta-analysis. J Cardiovasc Electrophysiol. 2016;27:161–9.PubMed
54.
Zurück zum Zitat Chokesuwattanaskul R, Thongprayoon C, Sharma K, Congrete S, Tanawuttiwat T, Cheungpasitporn W. Associations of sleep quality with incident atrial fibrillation: a meta-analysis. Intern Med J. 2018;48:964–72.PubMed Chokesuwattanaskul R, Thongprayoon C, Sharma K, Congrete S, Tanawuttiwat T, Cheungpasitporn W. Associations of sleep quality with incident atrial fibrillation: a meta-analysis. Intern Med J. 2018;48:964–72.PubMed
55.
Zurück zum Zitat Emdin CA, Odutayo A, Wong CX, Tran J, Hsiao AJ, Hunn BHM. Meta-analysis of anxiety as a risk factor for cardiovascular disease. Am J Cardiol. 2016;118:511–9.PubMed Emdin CA, Odutayo A, Wong CX, Tran J, Hsiao AJ, Hunn BHM. Meta-analysis of anxiety as a risk factor for cardiovascular disease. Am J Cardiol. 2016;118:511–9.PubMed
56.
Zurück zum Zitat Fransson EI, Nordin M, Magnusson Hanson LL, Westerlund H. Job strain and atrial fibrillation—results from the Swedish Longitudinal Occupational Survey of Health and meta-analysis of three studies. Eur J Prev Cardiol. 2018;25:1142–9.PubMed Fransson EI, Nordin M, Magnusson Hanson LL, Westerlund H. Job strain and atrial fibrillation—results from the Swedish Longitudinal Occupational Survey of Health and meta-analysis of three studies. Eur J Prev Cardiol. 2018;25:1142–9.PubMed
57.
Zurück zum Zitat Himmelreich JCL, Lucassen WAM, Heugen M, Bossuyt PMM, Tan HL, Harskamp RE, et al. Frequent premature atrial contractions are associated with atrial fibrillation, brain ischaemia, and mortality: a systematic review and meta-analysis. EP Eur. 2019;21:698–707. Himmelreich JCL, Lucassen WAM, Heugen M, Bossuyt PMM, Tan HL, Harskamp RE, et al. Frequent premature atrial contractions are associated with atrial fibrillation, brain ischaemia, and mortality: a systematic review and meta-analysis. EP Eur. 2019;21:698–707.
58.
Zurück zum Zitat Kim SY, Kim MJ, Cadarette SM, Solomon DH. Bisphosphonates and risk of atrial fibrillation: a meta-analysis. Arthritis Res Ther. 2010;12:R30.PubMedPubMedCentral Kim SY, Kim MJ, Cadarette SM, Solomon DH. Bisphosphonates and risk of atrial fibrillation: a meta-analysis. Arthritis Res Ther. 2010;12:R30.PubMedPubMedCentral
59.
Zurück zum Zitat Kwok CS, Anderson SG, Myint PK, Mamas MA, Loke YK. Physical activity and incidence of atrial fibrillation: a systematic review and meta-analysis. Int J Cardiol. 2014;177:467–76.PubMed Kwok CS, Anderson SG, Myint PK, Mamas MA, Loke YK. Physical activity and incidence of atrial fibrillation: a systematic review and meta-analysis. Int J Cardiol. 2014;177:467–76.PubMed
60.
Zurück zum Zitat Kwok CS, Rashid M, Beynon R, Barker D, Patwala A, Morley-Davies A, et al. Prolonged PR interval, first-degree heart block and adverse cardiovascular outcomes: a systematic review and meta-analysis. Heart. 2016;102:672–80.PubMed Kwok CS, Rashid M, Beynon R, Barker D, Patwala A, Morley-Davies A, et al. Prolonged PR interval, first-degree heart block and adverse cardiovascular outcomes: a systematic review and meta-analysis. Heart. 2016;102:672–80.PubMed
61.
Zurück zum Zitat Larsson SC, Drca N, Jensen-Urstad M, Wolk A. Coffee consumption is not associated with increased risk of atrial fibrillation: results from two prospective cohorts and a meta-analysis. BMC Med. 2015;13:207.PubMedPubMedCentral Larsson SC, Drca N, Jensen-Urstad M, Wolk A. Coffee consumption is not associated with increased risk of atrial fibrillation: results from two prospective cohorts and a meta-analysis. BMC Med. 2015;13:207.PubMedPubMedCentral
62.
Zurück zum Zitat Larsson SC, Drca N, Jensen-Urstad M, Wolk A. Chocolate consumption and risk of atrial fibrillation: two cohort studies and a meta-analysis. Am Heart J. 2018;195:86–90.PubMed Larsson SC, Drca N, Jensen-Urstad M, Wolk A. Chocolate consumption and risk of atrial fibrillation: two cohort studies and a meta-analysis. Am Heart J. 2018;195:86–90.PubMed
63.
Zurück zum Zitat Li F-R, Chen G-C, Qin J, Wu X. Dietary fish and long-chain n-3 polyunsaturated fatty acids intake and risk of atrial fibrillation: a meta-analysis. Nutrients. 2017;9:955.PubMedCentral Li F-R, Chen G-C, Qin J, Wu X. Dietary fish and long-chain n-3 polyunsaturated fatty acids intake and risk of atrial fibrillation: a meta-analysis. Nutrients. 2017;9:955.PubMedCentral
64.
Zurück zum Zitat Liu G, Yan Y-P, Zheng X-X, Xu Y-L, Lu J, Hui R-T, et al. Meta-analysis of nonsteroidal anti-inflammatory drug use and risk of atrial fibrillation. Am J Cardiol. 2014;114:1523–9.PubMed Liu G, Yan Y-P, Zheng X-X, Xu Y-L, Lu J, Hui R-T, et al. Meta-analysis of nonsteroidal anti-inflammatory drug use and risk of atrial fibrillation. Am J Cardiol. 2014;114:1523–9.PubMed
65.
Zurück zum Zitat Meng L, Yang Y, Zhang Z, Li G, Liu T. Predictive value of circulating fibroblast growth factor-23 on atrial fibrillation: a meta-analysis. Int J Cardiol. 2016;210:68–71.PubMed Meng L, Yang Y, Zhang Z, Li G, Liu T. Predictive value of circulating fibroblast growth factor-23 on atrial fibrillation: a meta-analysis. Int J Cardiol. 2016;210:68–71.PubMed
66.
Zurück zum Zitat Qi W, Zhang N, Korantzopoulos P, Letsas KP, Cheng M, Di F, et al. Serum glycated hemoglobin level as a predictor of atrial fibrillation: a systematic review with meta-analysis and meta-regression. PLoS ONE. 2017;12:e0170955.PubMedPubMedCentral Qi W, Zhang N, Korantzopoulos P, Letsas KP, Cheng M, Di F, et al. Serum glycated hemoglobin level as a predictor of atrial fibrillation: a systematic review with meta-analysis and meta-regression. PLoS ONE. 2017;12:e0170955.PubMedPubMedCentral
67.
Zurück zum Zitat Ricci C, Gervasi F, Gaeta M, Smuts CM, Schutte AE. Physical activity volume in relation to risk of atrial fibrillation. A non-linear meta-regression analysis. Eur J Prev Cardiol. 2018;25:857–66.PubMed Ricci C, Gervasi F, Gaeta M, Smuts CM, Schutte AE. Physical activity volume in relation to risk of atrial fibrillation. A non-linear meta-regression analysis. Eur J Prev Cardiol. 2018;25:857–66.PubMed
68.
Zurück zum Zitat Shang W, Li L, Huang S, Zeng R, Huang L, Ge S, et al. Chronic kidney disease and the risk of new-onset atrial fibrillation: a meta-analysis of prospective cohort studies. PLoS ONE. 2016;11:e0155581.PubMedPubMedCentral Shang W, Li L, Huang S, Zeng R, Huang L, Ge S, et al. Chronic kidney disease and the risk of new-onset atrial fibrillation: a meta-analysis of prospective cohort studies. PLoS ONE. 2016;11:e0155581.PubMedPubMedCentral
69.
Zurück zum Zitat Tse G, Wong CW, Gong M, Wong WT, Bazoukis G, Wong SH, et al. Predictive value of inter-atrial block for new onset or recurrent atrial fibrillation: a systematic review and meta-analysis. Int J Cardiol. 2018;250:152–6.PubMed Tse G, Wong CW, Gong M, Wong WT, Bazoukis G, Wong SH, et al. Predictive value of inter-atrial block for new onset or recurrent atrial fibrillation: a systematic review and meta-analysis. Int J Cardiol. 2018;250:152–6.PubMed
70.
Zurück zum Zitat Ungprasert P, Srivali N, Kittanamongkolchai W. Risk of incident atrial fibrillation in patients with rheumatoid arthritis: a systematic review and meta-analysis. Int J Rheum Dis. 2017;20:434–41.PubMed Ungprasert P, Srivali N, Kittanamongkolchai W. Risk of incident atrial fibrillation in patients with rheumatoid arthritis: a systematic review and meta-analysis. Int J Rheum Dis. 2017;20:434–41.PubMed
71.
Zurück zum Zitat Ungprasert P, Srivali N, Kittanamongkolchai W. Psoriasis and risk of incident atrial fibrillation: a systematic review and meta-analysis. Indian J Dermatol Venereol Leprol. 2016;82:489–97.PubMed Ungprasert P, Srivali N, Kittanamongkolchai W. Psoriasis and risk of incident atrial fibrillation: a systematic review and meta-analysis. Indian J Dermatol Venereol Leprol. 2016;82:489–97.PubMed
72.
Zurück zum Zitat Wijarnpreecha K, Boonpheng B, Thongprayoon C, Jaruvongvanich V, Ungprasert P. The association between non-alcoholic fatty liver disease and atrial fibrillation: a meta-analysis. Clin Res Hepatol Gastroenterol. 2017;41:525–32.PubMed Wijarnpreecha K, Boonpheng B, Thongprayoon C, Jaruvongvanich V, Ungprasert P. The association between non-alcoholic fatty liver disease and atrial fibrillation: a meta-analysis. Clin Res Hepatol Gastroenterol. 2017;41:525–32.PubMed
73.
Zurück zum Zitat Yan J, She Q, Zhang Y, Cui C, Zhang G. The association between arrhythmia and helicobacter pylori infection: a meta-analysis of case-control studies. Int J Environ Res Public Health. 2016;13:1139.PubMedCentral Yan J, She Q, Zhang Y, Cui C, Zhang G. The association between arrhythmia and helicobacter pylori infection: a meta-analysis of case-control studies. Int J Environ Res Public Health. 2016;13:1139.PubMedCentral
74.
Zurück zum Zitat Youssef I, Kamran H, Yacoub M, Patel N, Goulbourne C, Kumar S, et al. Obstructive sleep apnea as a risk factor for atrial fibrillation: a meta-analysis. J Sleep Disord Ther 2018;7(1):282.PubMedPubMedCentral Youssef I, Kamran H, Yacoub M, Patel N, Goulbourne C, Kumar S, et al. Obstructive sleep apnea as a risk factor for atrial fibrillation: a meta-analysis. J Sleep Disord Ther 2018;7(1):282.PubMedPubMedCentral
75.
Zurück zum Zitat Zhang C-H, Huang D-S, Shen D, Zhang L-W, Ma Y-J, Wang Y-M, et al. Association between serum uric acid levels and atrial fibrillation risk. Cell Physiol Biochem. 2016;38:1589–95.PubMed Zhang C-H, Huang D-S, Shen D, Zhang L-W, Ma Y-J, Wang Y-M, et al. Association between serum uric acid levels and atrial fibrillation risk. Cell Physiol Biochem. 2016;38:1589–95.PubMed
76.
Zurück zum Zitat Zhang N, Gong M, Tse G, Zhang Z, Meng L, Yan BP, et al. Prolonged corrected QT interval in predicting atrial fibrillation: a systematic review and meta-analysis. Pacing Clin Electrophysiol. 2018;41:321–7.PubMed Zhang N, Gong M, Tse G, Zhang Z, Meng L, Yan BP, et al. Prolonged corrected QT interval in predicting atrial fibrillation: a systematic review and meta-analysis. Pacing Clin Electrophysiol. 2018;41:321–7.PubMed
Metadaten
Titel
Environmental factors, serum biomarkers and risk of atrial fibrillation: an exposure-wide umbrella review of meta-analyses
verfasst von
Lazaros Belbasis
Michail C. Mavrogiannis
Maria Emfietzoglou
Evangelos Evangelou
Publikationsdatum
16.03.2020
Verlag
Springer Netherlands
Erschienen in
European Journal of Epidemiology / Ausgabe 3/2020
Print ISSN: 0393-2990
Elektronische ISSN: 1573-7284
DOI
https://doi.org/10.1007/s10654-020-00618-3

Weitere Artikel der Ausgabe 3/2020

European Journal of Epidemiology 3/2020 Zur Ausgabe